Transcode Therapeutics
RNAZ · NASDAQ
$1.68−$0.02 (−1.18%)TodayMarket closed ·
Prev close $1.70
Who owns RNAZ
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 35.5% of RNAZ’s shares.
- CK Life Sciences International Holdings, Inc.28.3%
- Sabby Management, LLC3.9%
- Yorkville Advisors Global, LP.1.9%
- Vanguard Capital Management, LLC0.6%
- Next 6 largest institutions0.8%
- All other shareholders64.5%
| Holder | Shares | % of shares |
|---|---|---|
| CK Life Sciences International Holdings, Inc. | 300.04K | 28.31% |
| Sabby Management, LLC | 41.60K | 3.92% |
| Yorkville Advisors Global, LP. | 19.64K | 1.85% |
| Vanguard Capital Management, LLC | 6.54K | 0.62% |
| Vanguard Fiduciary Trust Co | 2.98K | 0.28% |
| UBS Financial Services, Inc. | 2.89K | 0.27% |
| Tracy (Thomas Joseph) | 1.25K | 0.12% |
| Fidelity Management & Research Company LLC | 706 | 0.07% |
| Tower Research Capital LLC | 677 | 0.06% |
| Wells Fargo Advisors | 55 | 0.01% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Extended Market Index Fund | 6.54K | 0.62% |
| Fidelity Extended Market Index Fund | 5.11K | 0.48% |
| Fidelity Series Total Market Index Fund | 1.18K | 0.11% |
| Fidelity Total Market Index Fund | 510 | 0.05% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of RNAZ in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Fitzgerald Thomas A | Award | 185.00K | — |
| DEFJ, LLC | Other | 202 | — |
| DEFJ, LLC | Other | 1.18K | — |
| DEFJ, LLC | Other | 2.02M | — |
| DEFJ, LLC | Other | 11.81M | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 52.06K
- Days to cover
- 1.00
- % of shares outstanding
- 4.91%
- Average daily volume
- 68.42K
- Change since last report
- −15.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.